BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2026.
World J Cardiol. Jan 26, 2026; 18(1): 111954
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.111954
Figure 1
Figure 1 The pathophysiological mechanism of development of heart failure with preserved ejection fraction in metabolic dysfunction-associated liver disease. HFpEF: Heart failure with preserved ejection fraction; MASLD: Metabolic-dysfunction associated liver disease; A-V shunt: Arteriovenous shunt; BCAA: Branched-chain amino acid; MASH: Metabolic-associated steatohepatitis.


Write to the Help Desk